Scimedx Corp.

Scimedx Corp. — FDA 510(k) Submissions

Scimedx Corp. has submitted 14 FDA 510(k) premarket notifications since 1996, of which 14 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Test System, Antineutrophil Cytoplasmic Antibodies (anca), Autoantibodies, Endomysial(tissue Transglutaminase), Antibodies, Gliadin, Devices, Measure, Antibodies To Glomerular Basement Membrane (gbm), Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control . Use the specialty filter in the sidebar to narrow results.